Holen Sie sich die Stockscreener-App
0.1506
13.10%
-0.0234
Schlusskurs vom Vortag:
$0.174
Offen:
$0.1595
24-Stunden-Volumen:
1.20M
Relative Volume:
0.30
Marktkapitalisierung:
$1.12M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-5.65M
KGV:
-0.1203
EPS:
-1.2521
Netto-Cashflow:
$-5.88M
1W Leistung:
-6.95%
1M Leistung:
-29.51%
6M Leistung:
-75.95%
1J Leistung:
-84.50%
1-Tages-Spanne:
$0.15
$0.162
1-Wochen-Bereich:
$0.15
$0.28
52-Wochen-Spanne:
$0.15
$1.34
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Firmenname
Virax Biolabs Group Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare VRAX vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.151 | 1.29M | 3,000 | -5.65M | -5.88M | -1.2521 |
VRTX
Vertex Pharmaceuticals Inc
|
433.89 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.12 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.85 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.40 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.62 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Eingeleitet | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Aktie (VRAX) Neueste Nachrichten
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
VRAX Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Which stocks have an unusual volume on Wednesday? - ChartMill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Virax Biolabs subsidiary receives ISO quality certifications By Investing.com - za.investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Top movers in Tuesday's after hours session - ChartMill
Director Nelson Haight reports Virax Biolabs (VRAX) stock option awards - Stock Titan
Nasdaq most active stocks: - MSN
These stocks are making the most noise in today's session. - ChartMill
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Which stocks are experiencing notable movement on Tuesday? - ChartMill
What's Behind The Jump In Virax Biolabs Stock? - Benzinga
The market is filled with gapping stocks in Tuesday's session. - ChartMill
Discover the top movers in Tuesday's pre-market session. - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Virax adds medical-device quality standards as U.S. studies advance - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
If You Invested $1,000 in CDT Equity (CDT) - Stock Titan
If You Invested $1,000 in Virax Biolabs Group Ltd (VRAX) - Stock Titan
If You Invested $1,000 in Scinai Immunotherapeutics Ltd. (SCNI) - Stock Titan
Fundamentals Check: Does CIGC offer margin of safetyGDP Growth & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Virax Biolabs (NASDAQ: VRAX) COO discloses multiple long-dated stock options - Stock Titan
Virax Biolabs Shareholders Approve Reverse Split, New Charter and 2026 Equity Plan After Adjourned AGM - The Globe and Mail
Virax Biolabs (VRAX) backs reverse split range and 2M-share incentive plan - stocktitan.net
Virax Biolabs (VRAX) CEO reports holdings in shares and options - Stock Titan
Virax Biolabs Group Ltd (VRAX) director discloses multiple option grants - Stock Titan
Virax Biolabs (VRAX) CFO Jason Davis becomes reporting insider with Form 3 - Stock Titan
Virax Biolabs (VRAX) director files initial insider ownership report - Stock Titan
Momentum Shift: What are Virax Biolabs Group Limiteds earnings expectations2026 Trading Recap & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update - Defense World
00019 Should I Buy - Intellectia AI
PRH Should I Buy - Intellectia AI
VRAX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 67.6% in February - Defense World
ONEG.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MGR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
US Market Recap: Will Virax Biolabs Group Limited benefit from sector rotationJuly 2025 Intraday Action & Community Shared Stock Ideas - baoquankhu1.vn
Volume Summary: How much upside does HSDT haveWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
TCGL Should I Buy - Intellectia AI
Day Trade: Is now the right time to enter AEISWeekly Trend Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
SKX PE Ratio & Valuation, Is SKX Overvalued - Intellectia AI
VRAX PE Ratio & Valuation, Is VRAX Overvalued - Intellectia AI
Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Nektar Therapeutics (NKTR) - The Globe and Mail
IVF Should I Buy - Intellectia AI
Exit Recap: Is Oriental Culture Holding LTD stock risky to hold nowEarnings Summary Report & Short-Term High Return Ideas - baoquankhu1.vn
Virax Biolabs Sets March 11, 2026 AGM to Vote on Reverse Share Split and New Equity Plan - The Globe and Mail
Bull Bear: Does Virax Biolabs Group Limited offer margin of safetyMarket Activity Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
Finanzdaten der Virax Biolabs Group Ltd-Aktie (VRAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):